MEI Pharma is a pharmaceutical company in San Diego that develops treatments for cancer. Its products include Zandelisib and Voruciclib, which target B-cell malignancies and follicular lymphoma. The company also has collaborative agreements with several other companies including Helsinn Healthcare, Kyowa Kirin and BeiGene.